International Women’s Day Talks 2026

On International Women’s Day in Brussels, policymakers, experts, and stakeholders will confront a critical reality: women’s health in Europe remains under-prioritised, with persistent gaps in access, research, and policy implementation. From menopause and maternal mental health to neurology and oncology, structural inequities continue to shape outcomes, with tangible economic and societal consequences. The fault lines are clear, and the question is no longer whether action is needed—but whether political will can finally match the urgency. 

Join us for our International Women’s Day Talks, where we bring together glass-ceiling breakers MEPs for a conversation that promises to inspire and catalyse change.    

#IWDtalks

Interested in this event?

Event Details

- How can the EU Women’s Health Strategy support menopause care, and what funding mechanisms can be leveraged to ensure equitable access across member states?

- What economic impacts does menopause-related workforce attrition have on the EU, and how can policies mitigate these effects?

- How can EU institutions incentivise private and public sectors to implement workplace policies that support women experiencing menopause?

- How can EU policies support early detection and treatment of post-partum depression, particularly through cross-border healthcare programmes and funding initiatives?

- What is the economic impact of untreated maternal mental health conditions on the EU workforce and healthcare systems, and how can policy intervention reduce these costs?

- How can digital health solutions and EU research funding improve access to maternal mental health care in underserved regions?

- How can the EU’s Beating Cancer Plan be strengthened to better address gender-specific needs in oncology, particularly in under-recognized gynecological cancers where women face diagnostic delay and poorer outcomes?

- How can the forthcoming EU Women’s Health or Gender Equality Strategy for 2026–2030 better integrate cancer, ensuring that women’s cancer outcomes are not treated in isolation from broader women’s health priorities?

- What does Europe need to do to design healthcare systems that better reflect women’s needs in ovarian and gynaecological cancer care?

- In a crowded EU and national health agenda, how can outcomes for gynaecological cancers be kept high on the political priority list, and what would meaningful leadership look like in practice?

CEO
World Ovarian Cancer Coalition
Vice President Europe Region South
AbbVie
Reporter
The Parliament
(Renew, Estonia)
European Parliament
Medical Doctor - Head of clinical osteology
Frankfurt Bone Health Center
MEP (S&D, Germany)
European Parliament
MEP (The Left, Portugal)
European Parliament
MEP (Renew, Ireland)
European Parliament
President
European Committee of the Regions (CoR)
(S&D, Spain)
European Parliament
(Greens/EFA, Luxembourg)
European Parliament
MD & Independent Journalist
(Renew, Denmark)
European Parliament
Event Details
    Sponsors